| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |